Literature DB >> 17911146

Simvastatin co-prescribed with protease inhibitors despite dangerous drug interactions.

Katherine M Coyne, Marta Boffito, Nick Theobald, David Asboe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17911146      PMCID： PMC2598705          DOI： 10.1136/sti.2007.026070

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN： 1368-4973            Impact factor:   3.519


× No keyword cloud information.
  3 in total

1.  Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.

Authors:  C Bradley Hare; Mai P Vu; Carl Grunfeld; Harry W Lampiris
Journal:  Clin Infect Dis       Date:  2002-10-25       Impact factor: 9.079

2.  Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study.

Authors:  John G Gerber; Susan L Rosenkranz; Carl J Fichtenbaum; Jose M Vega; Amy Yang; Beverly L Alston; Susan W Brobst; Yoninah Segal; Judith A Aberg
Journal:  J Acquir Immune Defic Syndr       Date:  2005-07-01       Impact factor: 3.731

3.  Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

Authors:  Carl J Fichtenbaum; John G Gerber; Susan L Rosenkranz; Yoninah Segal; Judith A Aberg; Terrence Blaschke; Beverly Alston; Fang Fang; Bradley Kosel; Francesca Aweeka
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.